HOME >> MEDICINE >> NEWS
Heart failure medication does not improve survival, compared to more widely used medication

The drug levosimendan did not improve survival for patients with decompensated heart failure when compared with a more widely-used treatment for this condition, dobutamine, according to a study in the May 2 issue of JAMA.

Acute decompensated heart failure (ADHF; severe heart failure characterized by inability of the heart to maintain adequate blood circulation) remains a common cause of hospitalization worldwide, but appropriate treatment is not always clear. Dobutamine improves symptoms but has been associated with an increased risk of death and other cardiovascular events, according to background information in the article. In a previous study, secondary analyses indicated that the drug levosimendan was associated with lower risk of death compared to dobutamine.

Alexandre Mebazaa, M.D., Ph.D., of the Universit Paris Diderot and Hospital Lariboisire AP-HP, Paris, and colleagues with the SURVIVE trial (Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support) conducted a study in which the primary purpose of the trial was to assess long-term survival outcomes for 1,327 ADHF patients who received levosimendan or dobutamine. The trial was conducted at 75 centers in 9 countries and patients were randomized between March 2003 and December 2004. Patients received either intravenous levosimendan (n = 664) or intravenous dobutamine (n = 663).

The researchers found that during the 180 days after drug infusion, there were 173 deaths (26 percent) in the levosimendan group and 185 deaths in the dobutamine group (28 percent). There were no statistical differences between treatment groups for most secondary end points (all-cause death at 31 days, number of days alive and out of the hospital, patient global assessment, patient assessment of dyspnea (difficulty breathing) at 24 hours, and cardiovascular death at 180 days). Compared with dobutamine-treated patients, levosimendan-treated patients were less likely to expe
'"/>

Contact: Katherine Morales
214-648-3404
JAMA and Archives Journals
1-May-2007


Page: 1 2

Related medicine news :

1. Drug-eluting stent controversy explored in the American Heart Hospital Journal
2. Heart-failure patients benefit from pharmacist care
3. Study offers clues to Broken Heart Syndrome
4. Heart Failure 2007
5. UCLA neurologist honored with American Heart Associations Stroke Council Award
6. Heart failure: Mayo Clinic reveals abnormality in filling of the heart is frequent culprit
7. Heart catheters do not benefit patients
8. Heart Rhythm Society publishes final recommendations for heart patients
9. Heartburn drug may help to slow progression of chronic heart failure
10. Heart failure drugs may be beneficial for patients with hardening of the arteries
11. University of Kentucky Gill Heart researchers study abdominal aortic aneurysms

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... ... a new practice in Glendale. While the office will be the first ... breast augmentation, tummy tucks, buttock augmentation (Brazilian butt lift), as well as rhinoplasty, ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... are joining biomedical engineers from Carnegie Mellon University (CMU) to develop a new ... who have undergone open heart surgery. , The AGH/CMU team was recently awarded ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... management solution for chiropractors, announced today the launch of its integrated, HIPAA compliant, ... start running their virtual practice in under 90 seconds. , According to ...
(Date:8/31/2020)... ... August 31, 2020 , ... In an effort to give back to the ... percent of each hotel room booked with a special new rate code to benefit ... (RMHC-CNI) , effective immediately. Donations will be applied to any room type, any ...
(Date:8/28/2020)... ... August 28, 2020 , ... ... designed to help treat patients with respiratory conditions, including COVID-19, while reducing the ... and oxygen, but it captures exhaled gas and scrubs it free of carbon ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... SANTA CLARA, Calif. (PRWEB) , ... September 01, ... ... diagnostics, and analytical laboratory technologies, will host the Agilent Science and Technology ... , During this two-day symposium, Agilent will open a suite of Live webinars ...
(Date:9/1/2020)... ... 2020 , ... September is National Ovarian Cancer Awareness Month. Ovarian cancer ... cancer of the female reproductive system. The American Cancer Society estimates that in ... will die from this disease. Throughout the month of September, Women’s Excellence aims ...
(Date:8/28/2020)... (PRWEB) , ... August 28, 2020 , ... ... operator of primary care medical centers in Florida and San Antonio is happy ... its South Texas medical centers. , In this capacity he will serve as ...
Breaking Medicine Technology:
Cached News: